Effects of 1-kestose on microbiome changes caused by vonoprazan: a randomized, double-blind, placebo-controlled pilot study.
Satoshi FuruneTakahiro SuzukiTakashi HondaKenta YamamotoKazuhiro FurukawaMasanao NakamuraMasatoshi IshigamiFumie KinoshitaYoshihiro KadotaTakumi TochioYoshiharu ShimomuraYoshiki HirookaMitsuhiro FujishiroHiroki KawashimaPublished in: Journal of gastroenterology and hepatology (2023)
The potassium-competitive acid blocker caused dysbiosis in the placebo group; this effect was prevented by 1-kestose. Thus, 1-kestose may be useful in dysbiosis treatment.